Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 917 | 1036 | 923 | 582 | 1343 | - |
Fund Return | -8.33% | 3.6% | -7.75% | -16.52% | 6.08% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HONGDE Research Sele Alloc | 2.4B | -7.89 | -11.65 | - | ||
HONGDE select growth mix | 1.66B | -9.33 | -10.41 | - | ||
HONGDE Vision Return mix | 1.4B | -3.50 | -12.91 | - | ||
HONGDE Strategy Transition Eq | 1.09B | -4.59 | -15.23 | - | ||
HONGDE HongHua Flxbl Alloc | 464.47M | -4.07 | -13.62 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund Blue Chip Selected Mixed | 41.14B | 3.12 | -17.36 | - | ||
Foresight Growth Value Alloc A | 18.81B | -2.35 | -18.46 | - | ||
Foresight Balance Value 3Y Own A | 11.83B | 10.04 | -10.71 | - | ||
Penghua Jiangxin Sele Alloc C | 8.69B | 2.57 | -15.13 | - | ||
China Merchants Advanced Enterprise | 5.42B | -1.61 | 3.25 | 12.13 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
THE EXPORT-IMPORT BANK OF CHINA BOND 2021 3 | - | 4.82 | - | - | |
Lotus Health | CNE000000WY0 | 0.65 | 3.680 | +1.10% | |
Unilumin | CNE100001518 | 0.59 | 5.17 | +1.57% | |
Inner Mongolia Xingye Mining | CNE000000D24 | 0.57 | 14.30 | +1.71% | |
Sz Woer A | CNE1000000C6 | 0.57 | 12.45 | -1.97% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review